Virax Biolabs have announced the distribution of a Monkeypox Virus Antigen Rapid Test Kits which has been launched in markets accepting the CE mark, such as the European Union.

For use in point of care settings the kits can help healthcare professionals to accurately identify a monkeypox infection in people suspected of carrying the monkeypox virus with results typically available in 15 minutes. It also serves as a valuable initial screening test for individuals that have been exposed to monkeypox infected patients or a high-risk environment. The specialized diagnostic kits can be found by contacting the company's sales representatives.

Virax's Chairman of the Board and Chief Executive Officer, James Foster commented "I am very proud of our organization's ability to quickly bring this rapid antigen test kit to market to help combat the monkeypox outbreak. We are working diligently to distribute the kits as well as the previously announced Monkeypox and Varicella Zoster Viruses Real Time PCR Detection Kits into the hands of healthcare practitioners as quickly as possible."

The test kit is intended for in vitro qualitative detection of the monkeypox virus antigen in the oropharyngeal (throat) swabs and skin exudates of humans by colloidal gold immunochromatography. For professional use only.

• Fast – 15 minutes for results to be read by naked eye
• Convenient – sample tube with prefilled extraction buffer
• Early – identifies acute or early infection

Visit www.viraxbiolabs.com